BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)

CUSIP: 09061G101

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
192,975,286
Total 13F shares
187,877,952
Share change
+8,935,546
Total reported value
$11,153,815,095
Put/Call ratio
61%
Price per share
$59.43
Number of holders
532
Value change
+$560,366,672
Number of buys
245
Number of sells
339

Quarterly Holders Quick Answers

What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q4 2025

As of 31 Dec 2025, BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by 532 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 187,877,952 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Dodge & Cox, PRIMECAP MANAGEMENT CO/CA/, NORGES BANK, STATE STREET CORP, AQR CAPITAL MANAGEMENT LLC, VIKING GLOBAL INVESTORS LP, GEODE CAPITAL MANAGEMENT, LLC, and DIMENSIONAL FUND ADVISORS LP. This page lists 532 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.